Growing Pet Adoption – Pivotal for Future Pet Demand

Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) — According to market research and competitive intelligence provider Fact.MR, the global animal drug preparation market is estimated to be worth more than US$2 billion in 2022. and is expected to grow at a high CAGR value of 8.2% throughout the forecast years 2022-2032.

The COVID-19 outbreak forced employees to work from home and the unemployment rate rose. As a result, people have had more time to spend at home, which has boosted pet adoption rates around the world.

  • According to the APPA (American Pet Product Association), 90.5 million (70% of households present in the United States) of households in the United States own a pet.

This played a crucial role in driving the growth of the animal drug preparation market. Additionally, new innovations and product development have also amplified the performance of animal drug preparation. Major manufacturers are working hard to maintain a full line of chemical compounds to help veterinarians. Additionally, they focus on improving products and adding ingredients.

Get a sample PDF of this research report with a detailed table of contents:

https://www.factmr.com/connectus/sampthe?flag=S&rep_id=5796

According to Fact.MR analysis, the animal drug preparation market is set to grow owing to the growing awareness of the value of animal health and the benefits of animal drug preparation. Manufacturers need to focus on clinical studies to improve product safety and confidence. Preparation medications are available in several convenient forms. Additionally, pet prep pharmacies can customize the flavors of pet medications, making it easier to manage.

The Growing Importance of the Pharmacist Training for Compounding for Animals

Recently, there have been initiatives to incorporate more specific training for veterinarians, which was not traditionally included by many pharmacy schools in their curricula before. However, pharmacists, through independent continuing education, receive a majority of training specific to veterinary pharmacy, including compounding.

Moreover, in recent years, the preparation market has undergone a complete transformation due to an increase in the approval of the practice by owners. Aspects that favorably affect the target market include better understanding of the therapeutic indications of various drugs, increased availability and use of animal health insurance, and improved animal welfare activities.

Key insights from market research

  • The global animal drug preparation market is expected to expand at a CAGR of 8.2% and reach US$4,419.6 million by 2032.
  • The market posted a CAGR of 6.3% from 2017 to 2021.
  • Under product, CNS agents are valued at US$719 million in 2022.
  • North America led the global market with 65.4% share in 2021.
  • Animal drug compounding revenues are expected to grow at CAGRs of 8.4% and 10.3%, respectively, in North America and Latin America.

Talk to the analyst:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5796

Animal Drug Preparation Industry Research Segmentation

  • By product:
    • Anti-invective
      • Metronidazole
      • Ketoconazole
      • Other antibiotics
    • Anti-inflammatory
      • Prednisolone
      • Tramadol
      • Other anti-inflammatory
    • CNS officers
      • Potassium bromide
      • Gabapentin
      • Other CNS agents
    • Gastrointestinal drugs
      • Apomorphine
      • Ursodiol
      • Cisapride
      • Other gastrointestinal drugs
    • Others
  • By administration:
    • Oral
    • Injectable
    • Topical
    • Rectal
    • Ocular

Quick purchase: Veterinary drug Caggravating Market research report:

https://www.factmr.com/checkout/5796

Market development

Suppliers of animal medicine preparations are focusing on new product development and also investing in flavor customization. The major players are also focusing on the offering of Compound Medicines in various forms. Additionally, the focus on quality control and producer compliance will enhance market credibility in the coming years.

Additionally, the target market is crucial to bridge the gap between alternative veterinary treatment options and the lesser availability of approved drugs for animal medicine.

In the animal drug preparation market, inorganic tactics such as mergers and acquisitions are becoming popular.

  • As an illustration, Wedgewood Pharmacy successfully acquired Wildlife Pharmaceuticals and its subsidiary zoo pharm.

Obtaining FDA approval is a primary tactic for all manufacturers. They are taking steps to obtain FDA clearance for drug preparation.

  • For example, Wedgewood Pharmacy has obtained a license from the New York State regulatory authority to offer compound drugs.

Pet care is usually a very expensive affair that is beyond the reach of low-income households. Pet owners generally prefer going to licensed compounding pharmacies as they offer better services at a reasonable price.

More valuable information about the offer

Fact.MR, in its new offering, presents an unbiased analysis of the global Animal Drug Preparation Market, showcasing historical market data (2017-2021) and forecast statistics for the period 2022-2032.

The study reveals essential information on the basis of product (anti-infectives, anti-inflammatories, CNS agents, gastrointestinal drugs, others), route of administration (oral, injection, topical, rectal, ocular), type animal (companion, livestock), and dosage form (capsules, suspension, solutions, powders, others), in major regions of the world (North America, Latin America, Europe, East Asia, South Asia and ASEAN, Oceania, Middle East and Africa).

Check out other related studies published by Fact.MR Research:

MRI Guided Drug Delivery Market – MRI Guided Drug Delivery or Magnetic Resonance Guided Drug Delivery is part of an advanced drug delivery system that helps transport a therapeutic agent from the delivery site to the targeted area. The growing demand for MRI-guided drug delivery is due to its non-invasive or minimally invasive approach, which causes fewer side effects and less pain compared to other alternatives.

Parenteral Drugs Market – The parenteral drugs market is poised to reach a staggering valuation of US$802 billion by the end of the forecast period 2019-2029. Parenteral drug manufacturers are currently focused on maintaining the high quality of their products. Single-use technology maintains the quality of biological parenteral drugs. Additionally, manufacturers are striving to incorporate quality by design (QbD) into their processes.

Animal Antibiotics Market – Animal antibiotics are gaining ground in case of prevention and treatment of diseases in animals, mainly bacterial diseases. The use of animal antibiotics has become very imperative in the animal welfare program, which is driving the adoption rate of animal antibiotics. Widespread implementation of “prevention is better than cure” in animal welfare is strengthening the vigor of animal antibiotics.

Animal Probiotics Market – Animal probiotics are widely accepted today, and rapidly evolving technology related to molecular biology and gene sequencing are helping researchers dig deep to explore new probiotic applications for animals. Over time, livestock and beef producers have increased the adoption of animal probiotics for commercial poultry and livestock feed to alter gastrointestinal flora, which continues to drive probiotic sales. animals, which has a positive impact on the animal probiotics market.

Animal Models Market – The animal models market is expected to be worth US$1.7 billion in 2022, growing to US$2.9 billion by 2032, documenting a CAGR of 5.5% from 2022 to 2032. Over the period of Estimated from 2022 to 2032, the demand for animal models in academic and research institutions is expected to increase at a CAGR of 6%. In 2021, the industry was valued at US$1.6 billion and is expected to grow at an annual expansion rate of 6.2% in 2022.

Cox 2 Inhibitors Market – Cox 2 inhibitors are a type of nonsteroidal anti-inflammatory drugs. These drugs are responsible for decreasing the production of prostaglandins. Rising prevalence of chronic diseases, such as rheumatoid arthritis, osteoarthritis, and other diseases is expected to increase the cox 2 inhibitors market growth. Increased awareness of physical activities can lead to sports injuries which is also expected to boost the cox 2 inhibitors market.

About Us:

Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide range – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.

Contact:
Mahendra Singh
USA Sales Office:
11140 Rockville Pike
Office 400
Rockville, MD 20852
Email: [email protected]
Tel: +1 (628) 251-158


Source link

Back To Top